Other SMARCB1 deficient cancers include epithelioid sarcomas (ES) and malignant rhabdoid tumors (MRTs), called atypical teratoid rhabdoid tumors (ATRTs) when developing in the central nervous system (CNS). Here, SMARCB1 is linked to rhabdoid tumor.